October 23, 2015
Rite Aid pharmacy devastated by riots celebrated its grand reopening in a special event attended by School of Pharmacy Dean Natalie Eddington and city and community leaders.
October 19, 2015
Award recognizes rising pharmacy educator’s outstanding contributions to the discipline of teaching and to the education of health care practitioners.
October 1, 2015
Project Homeless Connect helped more than 2,000 individuals experiencing homelessness in Baltimore receive an array of health care and social services.
September 24, 2015
David Stewart Associates Dinner recognizes individuals who participate in leadership level giving to the School.
September 22, 2015
Time-honored ceremony emphasizes professionalism and celebrates the start of the Class’s journey as student pharmacists.
September 18, 2015
Award honors pharmacy practitioners who have demonstrated exceptional leadership in enhancing health care quality and medication use among patients throughout their careers.
September 17, 2015
Week-long workshop featured presentations, panel discussions, and other activities designed to broaden participants’ knowledge of comparative effectiveness research and patient-centered outcomes research.
September 8, 2015
Dr. Magaly Rodriguez de Bittner will work with the School’s leadership to cultivate and advance innovative clinical practice and practice-based research initiatives across the University and beyond.
September 1, 2015
Guidelines aim to increase patients’ access to naloxone by educating pharmacists on the use and administration of this lifesaving medication.
August 28, 2015
More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.
August 25, 2015
Incoming Doctor of Pharmacy (PharmD) and graduate students participate in week of fun, informative activities to gain familiarity with the School and campus community.
August 14, 2015
Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.
